Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

Bartsch, R; Berghoff, AS; Furtner, J; Marhold, M; Bergen, ES; Roider-Schur, S; Starzer, AM; Forstner, H; Rottenmanner, B; Dieckmann, K; Bago-Horvath, Z; Haslacher, H; Widhalm, G; Ilhan-Mutlu, A; Minichsdorfer, C; Fuereder, T; Szekeres, T; Oehler, L; Gruenberger, B; Singer, CF; Weltermann, A; Puhr, R; Preusser, M

Preusser, M (通讯作者)，Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria.

NATURE MEDICINE, 2022; 28 (9): 1840

Abstract

Findings from the TUXEDO-1 trial demonstrate efficacy of the antibody-drug conjugate trastuzumab deruxtecan for treatment of brain metastases in patie......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索